EVFM 8-K 2026-09-23

Evofem Biosciences, Inc. (EVFM) 8-K dated 2026-09-23 — accession 0001493152-26-043919. This URL is the filing, not the EVFM hub.

Evofem Biosciences, Inc. (EVFM) is a biotechnology company listed on US.

Evofem Biosciences, Inc. filed a 8-K on 2026-09-23. Accession 0001493152-26-043919.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported EVFM revenue for 2025-12-31 was $20.2M. Net income was $391.0K. Revenue was up 4.2% from 2024-12-31 to 2025-12-31. EVFM currently screens at market cap $927.7K.

Not investment advice. The EVFM SEC hub lists recent forms. The stock page is the research view.